| Catalog Number |
03P36-25 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
06/29/2017
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Lot/serial number was not provided by the customer; therefore, only a partial udi is known an evaluation is in process.A follow-up report will be submitted when the evaluation is complete.An evaluation is in-process.
|
| |
|
Event or Problem Description
|
|
The customer observed a falsely elevated afp result for one patient while using the architect afp assay.The customer provided the following data (ng/ ml): (b)(6) 2017: sid (b)(6): initial: 50.89, retest after centrifugation: 31.11.The specimen from (b)(6) 2017 was retested on (b)(6) 2017: retests: 6.28 and 6.01 a second specimen was tested on (b)(6) 2017: initial 4.11 ng/ml there was no adverse impact to patient management reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, design history record (dhr) review, and a review of labeling.Tracking and trending did not identify an adverse trend or any atypical complaint activity.The dhr review did not identify any potential non-conformances, non-conformances or deviations related to the complaint issue.Labeling was reviewed and found to be adequate.Based on the available information a deficiency of the architect afp reagent, list 03p36, was not identified.
|
| |
|
Search Alerts/Recalls
|